Innovate or Stagnate: Overcoming Model Governance Challenges in Life Sciences
By treating model governance as a proactive, integral part of operations rather than a box to check after the fact, life sciences organizations can uphold compliance, better allocate their resources, and gain a competitive edge. The post Innovate or Stagnate: Overcoming Model Governance Challenges in Life Sciences appeared first on MedCity News.
By treating model governance as a proactive, integral part of operations rather than a box to check after the fact, life sciences organizations can uphold compliance, better allocate their resources, and gain a competitive edge.
The post Innovate or Stagnate: Overcoming Model Governance Challenges in Life Sciences appeared first on MedCity News.
